Loading...
patent
Use of igf-1 and nt-3 in the treatment of x-linked adrenoleukodystrophy
2010
The present invention is directed to new compositions uses thereof and related methods for the treatment of X- linked adrenoleukodystrophy.
Type
patent
EPO Family ID
42104387
Author(s)
Note
Alternative title(s) : (fr) Utilisation de igf-1 et de nt-3 dans le traitement d'une adrénoleucodystrophie à liaison x
TTO classification
TTO:6.0880
| DOI | Country code | Kind code | Date issued |
WO2010089706 | WO | A1 | 2010-08-12 |
Available on Infoscience
September 22, 2015
Use this identifier to reference this record